drug · Product Intelligence

Intranasal Oxytocin
Pipeline Intelligence

Intranasal Oxytocin: 6 indexed trials, 5 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
6Indexed trials
▦
5Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT01256060Evdokia Anagnostou · autismPHASE2
NCT01680718University of California, Los Angeles · out_of_scopeEARLY_PHASE1
NCT02493426University of Minnesota · autismPHASE2
NCT02888574University of Calgary · pain_neuropathyPHASE2, PHASE3
NCT02985749Massachusetts General Hospital · autismPHASE3
NCT03337035Massachusetts General Hospital · autismPHASE1

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.